Mark Sheptoff Financial Planning, LLC Moderna, Inc. Transaction History
Mark Sheptoff Financial Planning, LLC
- $186 Million
- Q3 2024
A detailed history of Mark Sheptoff Financial Planning, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Mark Sheptoff Financial Planning, LLC holds 210 shares of MRNA stock, worth $8,559. This represents 0.01% of its overall portfolio holdings.
Number of Shares
210
Previous 10
2000.0%
Holding current value
$8,559
Previous $1,000
1300.0%
% of portfolio
0.01%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding MRNA
# of Institutions
953Shares Held
241MCall Options Held
10.6MPut Options Held
18.7M-
Baillie Gifford & CO42.5MShares$1.73 Billion2.17% of portfolio
-
Vanguard Group Inc Valley Forge, PA40.2MShares$1.64 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$1.04 Billion0.07% of portfolio
-
State Street Corp Boston, MA16.8MShares$687 Million0.05% of portfolio
-
Theleme Partners LLP London, X07.23MShares$295 Million28.47% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $15.9B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...